Answer
Rifampicin, a CYP3A4 inducer, may reduce plasma macimorelin concentrations and affect the diagnostic performance of the macimorelin acetate test; its use should be avoided, with a washout of five rifampicin elimination half-lives recommended before testing.
Sources for this answer
- MACIMORELIN 60 mg granules for oral suspension in sachetAtnahs Pharma UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 2Document updated
Sources checked